{"entity":{"type":"insider","cik":"0001873731","url":"/insider/0001873731","json_url":"/insider/0001873731.json","name":"Silver Ronald","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":16,"first":"2021-08-18","last":"2026-07-09","span_basis":"filed_date"},"name_variants":[{"name":"Silver Ronald","source":"filing","n_filings":16,"first_seen":"2021-08-18","last_seen":"2026-07-09"}],"transactions":[{"id":6178300,"accession":"0001193125-26-299749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-299749","line_url":"/filing/0001193125-26-299749#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (PFO & PAO)","role_mark":"O","role_mark_label":"Officer (PFO & PAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PFO & PAO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127890.0,"shares_display":"127,890","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":578062.8,"total_display":"578,062.80","total_whole":"578,063","shares_owned_after":313680.0,"shares_owned_after_display":"313,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-09","scope":"insider"},{"id":5904695,"accession":"0001193125-26-071495","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-071495","line_url":"/filing/0001193125-26-071495#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12621.0,"shares_display":"12,621","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":46192.86,"total_display":"46,192.86","total_whole":"46,193","shares_owned_after":252636.0,"shares_owned_after_display":"252,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":5904694,"accession":"0001193125-26-071495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-071495","line_url":"/filing/0001193125-26-071495#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11552.0,"shares_display":"11,552","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":44013.12,"total_display":"44,013.12","total_whole":"44,013","shares_owned_after":265257.0,"shares_owned_after_display":"265,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5870133,"accession":"0001193125-26-006290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006290","line_url":"/filing/0001193125-26-006290#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35416.0,"shares_display":"35,416","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":162913.6,"total_display":"162,913.60","total_whole":"162,914","shares_owned_after":276809.0,"shares_owned_after_display":"276,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4342142,"accession":"0000950170-25-108011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-108011","line_url":"/filing/0000950170-25-108011#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2846.0,"shares_display":"2,846","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":2390.64,"total_display":"2,390.64","total_whole":"2,391","shares_owned_after":276809.0,"shares_owned_after_display":"276,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":5196266,"accession":"0000950170-25-019236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-019236","line_url":"/filing/0000950170-25-019236#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12048.0,"shares_display":"12,048","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":21204.48,"total_display":"21,204.48","total_whole":"21,204","shares_owned_after":279655.0,"shares_owned_after_display":"279,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":2737516,"accession":"0000950170-24-097182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-097182","line_url":"/filing/0000950170-24-097182#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3107.0,"shares_display":"3,107","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":13266.89,"total_display":"13,266.89","total_whole":"13,267","shares_owned_after":158370.0,"shares_owned_after_display":"158,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":2080548,"accession":"0000950170-24-015553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-015553","line_url":"/filing/0000950170-24-015553#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7908.0,"shares_display":"7,908","price_per_share":15.24,"price_display":"15.24","price_state":"stated","total_value":120517.92,"total_display":"120,517.92","total_whole":"120,518","shares_owned_after":134264.0,"shares_owned_after_display":"134,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":8023130,"accession":"0001209191-23-046018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046018","line_url":"/filing/0001209191-23-046018#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1976.0,"shares_display":"1,976","price_per_share":10.04,"price_display":"10.04","price_state":"stated","total_value":19839.04,"total_display":"19,839.04","total_whole":"19,839","shares_owned_after":134172.0,"shares_owned_after_display":"134,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider"},{"id":7967838,"accession":"0001209191-23-014286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014286","line_url":"/filing/0001209191-23-014286#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3049.0,"shares_display":"3,049","price_per_share":11.31,"price_display":"11.31","price_state":"stated","total_value":34484.19,"total_display":"34,484.19","total_whole":"34,484","shares_owned_after":98491.0,"shares_owned_after_display":"98,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider"},{"id":7967834,"accession":"0001209191-23-014286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-014286","line_url":"/filing/0001209191-23-014286#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2929.0,"shares_display":"2,929","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":33419.89,"total_display":"33,419.89","total_whole":"33,420","shares_owned_after":101540.0,"shares_owned_after_display":"101,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider"},{"id":6826685,"accession":"0001209191-22-058612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058612","line_url":"/filing/0001209191-22-058612#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682.0,"shares_display":"682","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":7883.92,"total_display":"7,883.92","total_whole":"7,884","shares_owned_after":104469.0,"shares_owned_after_display":"104,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6305446,"accession":"0001209191-22-046225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-046225","line_url":"/filing/0001209191-22-046225#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2014.0,"shares_display":"2,014","price_per_share":11.77,"price_display":"11.77","price_state":"stated","total_value":23704.78,"total_display":"23,704.78","total_whole":"23,705","shares_owned_after":105151.0,"shares_owned_after_display":"105,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6752393,"accession":"0001209191-22-031843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-031843","line_url":"/filing/0001209191-22-031843#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":1380.0,"total_display":"1,380.00","total_whole":"1,380","shares_owned_after":105073.0,"shares_owned_after_display":"105,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":6295649,"accession":"0001209191-22-021097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021097","line_url":"/filing/0001209191-22-021097#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3031.0,"shares_display":"3,031","price_per_share":12.75,"price_display":"12.75","price_state":"stated","total_value":38645.25,"total_display":"38,645.25","total_whole":"38,645","shares_owned_after":105193.0,"shares_owned_after_display":"105,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-03-25","scope":"insider"},{"id":6723266,"accession":"0001209191-22-014661","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-014661","line_url":"/filing/0001209191-22-014661","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2238.0,"shares_display":"2,238","price_per_share":10.77,"price_display":"10.77","price_state":"stated","total_value":24103.26,"total_display":"24,103.26","total_whole":"24,103","shares_owned_after":61211.0,"shares_owned_after_display":"61,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider","n_lines":3},{"id":4904220,"accession":"0001209191-21-066779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066779","line_url":"/filing/0001209191-21-066779","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1462.0,"shares_display":"1,462","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":16929.96,"total_display":"16,929.96","total_whole":"16,930","shares_owned_after":61926.0,"shares_owned_after_display":"61,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":4573251,"accession":"0001209191-21-052207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052207","line_url":"/filing/0001209191-21-052207#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001873731","owner_name":"Silver Ronald","owner_display_name":"Silver Ronald","owner_url":"/insider/0001873731","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":567.0,"shares_display":"567","price_per_share":13.48,"price_display":"13.48","price_state":"stated","total_value":7643.16,"total_display":"7,643.16","total_whole":"7,643","shares_owned_after":62675.0,"shares_owned_after_display":"62,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (PFO & PAO)","n_filings":16,"first_seen":"2021-08-18","last_seen":"2026-07-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001873731","retrieved_at":"2026-08-26T00:59:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}